Posts Tagged 'Samsca'

FDA warns Samsca linked to liver injury

The U.S. Food and Drug Administration has issued a warning that the kidney drug tolvaptan, sold under the brand name “Samsca,” carries a risk of liver injuries, “potentially leading to liver transplant or death.”

According to a story on MedPage Today, the drug is used to treat low serum sodium levels.

Last January, the company that markets the drug, Otsuka American Pharmaceutical, notified physicians that it was linked to liver injury.

In a letter ...

continue reading...